Article Sidebar
Published:
Mar 4, 2017DOI:
10.4314/tjpr.v16i3.2Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Antiproliferative effects of isoprenoids from Sarcophyton glaucum on breast cancer MCF-7 cells
Abstract
Purpose: To evaluate the anticancer activity of isoprenoids of Sarcophyton glaucum on MCF-7 cells and to investigate the potential synergistic effect of doxorubicin.
Methods: Isolation and purification of isoprenoids were performed by applying different planar chromatographic methods (CC and PTLC). Further analyses of the isoprenoids by nuclear magnetic resonance (NMR) and mass spectrometry (MS) carried out to identify the compounds. Sulforhodamine- B (SRB) assay was used to determine the cytotoxic activity of the compounds against the MCF-7 human cell line. Flow cytometric analysis was used to assess their impact on cell cycle of MCF-7. Combination index (CI), when the compounds were combined with doxorubicin, was calculated to determine possible synergism. The isoprenoid compounds were also incubated at ¼ or ½ of their respective half-maximal concentration (IC50) with equimolar concentrations of doxorubicin.
Results: Four known isoprenoid derivatives (1-4) were identified as 10(14)-aromadendrene (1), sarcophinediol (2), ent-deoxysarcophine (3) and sarcotrocheliol acetate (4). It was observed that cells accumulated in pre-G phase as well. CI of compound 3 with doxorubicin was 0.67 and 0.79, respectively, at ¼ and ½ of IC50, indicating overt synergism. This was confirmed by re-assessing the cell cycle stages of MCF-7 cells.
Conclusion: The results indicate that compound 3 exhibits promising cytotoxicity as well as synergism with doxorubicin in MCF-7 cells. This is attributed, at least partly, to its ability to generate intercellular apoptosis induction.
Keywords: Sarcophyton glaucum, Combination index, Antiproliferation, Isoprenoidal derivatives, 10(14)-Aromadendrene,Sarcophinediol, Deoxysarcophine, Sarcotrocheliol acetate, Doxorubicin
